UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas : vimarsana.com

A multidisciplinary team of University of Cincinnati Cancer Center researchers have opened a Phase 2 clinical trial to test a new combination treatment for glioblastomas (GBM), the most deadly form of brain tumors.

Related Keywords

Cincinnati , Ohio , United States , Phoenix , Arizona , University Of Cincinnati , American , Lalanthica Yogendran , Shesh Rai , Rekha Chaudhary , Pankaj Desai , Biplab Dasgupta , Gary Gudelsky , Mario Medvedovic , Catalyst Research Award , Uc Jamesl Winkle College Of Pharmacy , Falk Medical Research , Clinical Cancer Research , University Of Cincinnati Cancer Center , Division Of Hematology Oncology , Brain Tumor Center , Marian Falk Medical Research , American Association For Cancer Research , Uc Brain Tumor Center , Sciences Division , Uc College Of Medicine , Cincinnati Cancer Center , Trisha Wise Draper , Marian Falk Medical Research Trust , Tumor Center , Pharmaceutical Sciences Division , American Association , Medical Oncology , Soma Sengupta , Applied Science , Cincinnati Children , Walk Ahead , Brain Tumor Discoveries , Falk Catalyst Award , Falk Medical Research Trust , National Institutes , National Institute , Neurological Disorders , David Plas , Tim Phoenix , Brain , Rain Tumor , Ancer , Umor , Lood , Reast Cancer , Atalyst , Hemotherapy , Linical Trial , Rugs , Nzyme , Edical Research , Edicine , Euro Oncology , Ncology , Harmacodynamics , Harmacy , Reclinical , Esearch , Urgery ,